Fried Robert N

Fried Robert N is listed in filings as Chief Executive Officer at Niagen Bioscience Inc. This profile follows SEC Form 4 activity through Apr 27, 2026, including 5 public disclosures. Recent filings connect the profile to Niagen Bioscience Inc (NAGE) and ChromaDex Corporation (CDXC). The current snapshot covers public activity from Feb 14, 2025 to Apr 27, 2026. Reported amounts are shown as $52.2K to $220.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.